Legacy App users can now access the Health Portal – just reset your password using email as username.

Should You Split Your Weekly Testosterone Dose?

Should You Split Your Weekly Testosterone Dose?

Viewing This Video Is A Member Exclusive Feature

But you don’t need membership to get Dr. O’Connor’s insight on this topic, it’s in the summary, key takeaways, and related drugs and conditions below.

Want to watch the full video? Join the Health Portal Today.

Join Now

Timeline

Timestamp
Topic
00:00
A 55-year-old man asks whether he should continue splitting his weekly testosterone into two injections or take the full dose once weekly. Dr. O’Connor explains that dosing frequency depends on how well the individual tolerates the peaks and troughs associated with once-weekly dosing.
01:30
Dr. O’Connor cautions against repeatedly donating blood without also evaluating iron status. He recommends monitoring the CBC, iron, and ferritin so elevated hematocrit and the effects of blood donation can be evaluated more completely.

Video Summary

Splitting a weekly testosterone dose may help some men manage hormone fluctuations and elevated hematocrit. Dr. O’Connor addresses a 55-year-old man injecting testosterone twice weekly who asks whether he should continue splitting his dose or switch to one weekly injection. He explains that the choice depends on how the individual tolerates the peaks and troughs associated with once-weekly dosing.

The discussion then turns to a hematocrit of 53 and the man’s need to donate blood every month or two. Dr. O’Connor notes that hematocrit can rise with testosterone and says there may be some benefit to splitting the dose if it reduces or slows erythrocytosis. He emphasizes, however, that the response is highly individual.

Several factors may contribute to elevated hematocrit, including sleep apnea, excess weight, genetics, diet, age, and androgen dose. Dr. O’Connor also notes that higher amounts of testosterone and the use of other drugs such as Equipoise can further increase hematocrit.

Before repeatedly donating blood, Dr. O’Connor recommends evaluating iron status rather than focusing on hematocrit alone. He advises monitoring the CBC along with iron and ferritin and encourages reviewing these laboratory results when making decisions about ongoing testosterone management.

Drug Callouts

Drug
Description
Testosterone
Testosterone is discussed in relation to weekly injection frequency and elevated hematocrit. Dr. O’Connor explains that some men tolerate once-weekly dosing while others may prefer split dosing, and he notes that higher testosterone doses can further increase hematocrit.
Equipoise
Equipoise is mentioned as another androgen that can contribute to increased hematocrit. Dr. O’Connor notes that combining higher amounts of testosterone with Equipoise or other drugs can further increase this effect.

Condition Callouts

Condition
Description
Erythrocytosis
Erythrocytosis is discussed as an increase in red blood cell concentration associated with testosterone and other contributing factors. Dr. O’Connor says splitting a testosterone dose may reduce or slow this response in some men, although the effect varies by individual.
Sleep Apnea
Sleep apnea is identified as one of several factors that may contribute to elevated hematocrit in men using testosterone. Dr. O’Connor emphasizes that the tendency toward erythrocytosis is influenced by more than testosterone dosing alone.

Key Takeaways

  • Once-weekly or twice-weekly testosterone dosing can be appropriate depending on how an individual tolerates hormonal peaks and troughs.
  • Splitting a testosterone dose may help reduce or slow erythrocytosis in some men, but the response is highly individual.
  • Sleep apnea, excess weight, genetics, diet, age, and androgen dose can all influence hematocrit.
  • Higher testosterone doses and other androgens such as Equipoise can further increase hematocrit.
  • Repeated blood donation should not be considered without also monitoring iron and ferritin levels.
  • CBC, iron, and ferritin testing can provide a more complete picture when managing elevated hematocrit during testosterone use.